Daiwa Securities Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-75
| Closed | -$4K | – | 1198 |
|
|
2025
Q4 | $4K | Sell |
75
-30
| -29% | -$1.17K | ﹤0.01% | 1250 |
|
|
2025
Q3 | $3K | Hold |
105
| – | – | ﹤0.01% | 1234 |
|
|
2025
Q2 | $2K | Hold |
105
| – | – | ﹤0.01% | 1204 |
|
|
2025
Q1 | $2K | Hold |
105
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q4 | $1K | Hold |
105
| – | – | ﹤0.01% | 1245 |
|
|
2024
Q3 | $4K | Hold |
105
| – | – | ﹤0.01% | 1173 |
|
|
2024
Q2 | $3K | Hold |
105
| – | – | ﹤0.01% | 1223 |
|
|
2024
Q1 | $2K | Hold |
105
| – | – | ﹤0.01% | 1258 |
|
|
2023
Q4 | $2K | Hold |
105
| – | – | ﹤0.01% | 1263 |
|
|
2023
Q3 | $2K | Hold |
105
| – | – | ﹤0.01% | 1210 |
|
|
2023
Q2 | $2K | Hold |
105
| – | – | ﹤0.01% | 1225 |
|
|
2023
Q1 | $2K | Hold |
105
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q4 | $3K | Hold |
105
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q3 | $3K | Hold |
105
| – | – | ﹤0.01% | 1187 |
|
|
2022
Q2 | $2K | Buy |
105
+45
| +75% | +$997 | ﹤0.01% | 1220 |
|
|
2022
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 1291 |
|
|
2021
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 1271 |
|
|
2021
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 1237 |
|
|
2021
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 1132 |
|
|
2021
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 1184 |
|
|
2020
Q4 | $1K | Sell |
60
-112
| -65% | -$2.72K | ﹤0.01% | 1161 |
|
|
2020
Q3 | $3K | Hold |
172
| – | – | ﹤0.01% | 1111 |
|
|
2020
Q2 | $2K | Hold |
172
| – | – | ﹤0.01% | 1154 |
|
|
2020
Q1 | $2K | Hold |
172
| – | – | ﹤0.01% | 1153 |
|
|
2019
Q4 | $3K | Hold |
172
| – | – | ﹤0.01% | 1141 |
|
|
2019
Q3 | $6K | Hold |
172
| – | – | ﹤0.01% | 1062 |
|
|
2019
Q2 | $10K | Hold |
172
| – | – | ﹤0.01% | 1054 |
|
|
2019
Q1 | $13K | Buy |
172
+42
| +32% | +$2.9K | ﹤0.01% | 1016 |
|
|
2018
Q4 | $8K | Hold |
130
| – | – | ﹤0.01% | 1007 |
|
|
2018
Q3 | $13K | Hold |
130
| – | – | ﹤0.01% | 1016 |
|
|
2018
Q2 | $9K | Hold |
130
| – | – | ﹤0.01% | 1057 |
|
|
2018
Q1 | $14K | Buy |
+130
| New | +$14.7K | ﹤0.01% | 1006 |
|
Other funds holding ANAB
EC
TCM
AAA
PAI
6CM
Daiwa Securities Group's ANAB Position: Q1 2026 in Review
Daiwa Securities Group sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 75 shares — an estimated $4K sold.
Daiwa Securities Group first reported a position in ANAB in Q1 2018 and held it in 32 quarters. The position peaked at $14K in Q1 2018. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Daiwa Securities Group reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 75 AnaptysBio shares in Q1 2026, an estimated $4K.
- Daiwa Securities Group first reported a position in AnaptysBio in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's AnaptysBio position peaked at $14K in Q1 2018.
- 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.